| Amount | Holding | 
|---|---|
| 3.71% | Roche Holding AG ADR | 
| 3.08% | Kao Corp | 
| 2.91% | Novo Nordisk A/S B | 
| 2.74% | Vonovia SE | 
| 2.74% | Novartis AG ADR | 
| 2.62% | Unilever NV ADR | 
| 2.51% | Royal Philips NV | 
| 2.39% | Essity AB Class B | 
| 2.33% | Sampo Oyj Class A | 
| 2.30% | Daikin Industries Ltd | 
Expense Ratio Rating
6 /10
Expense Rating
0 /10
Market Score
3 /10
Category Score
8 /10
Market Size
3 /10
Boston Common ESG Impact International Fund
Expenses: 1.00% (Better than 1% of similar funds)
This is a bad choice for a Large Growth International Stocks fund. See why »
| Amount | Holding | 
|---|---|
| 3.71% | Roche Holding AG ADR | 
| 3.08% | Kao Corp | 
| 2.91% | Novo Nordisk A/S B | 
| 2.74% | Vonovia SE | 
| 2.74% | Novartis AG ADR | 
| 2.62% | Unilever NV ADR | 
| 2.51% | Royal Philips NV | 
| 2.39% | Essity AB Class B | 
| 2.33% | Sampo Oyj Class A | 
| 2.30% | Daikin Industries Ltd | 
Minafi - The intersection of FI, minimalism & mindfulness.
Don't miss out on new posts, courses, interactive articles and more!
Join & Get Your First Course Free© 2025 Adam Fortuna
Site Map